Redsense Medical AB hereby announces that ShapeQ GmbH has passed the disclosure threshold of 10 percent shareholding.

Through a recent share purchase, ShapeQ GmbH has acquired 750,000 shares which means a total holding of shares is 1,721,090 after the share purchase transaction, corresponding to approximately 12.3 percent of the votes and capital in Redsense Medical AB.

Contact information

For more information, please contact: 
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862